PAR 0.00% 22.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-376

  1. 9,814 Posts.
    lightbulb Created with Sketch. 1249
    Further to your conjecture on 1.5 v 2 mg studies. My understanding is effect size is close in aggregate BUT 2 mg is better for primary end points on pain and function. Read SW comments on confidence in achieving strong data set to allow PAR to monetise before read out. SW has chosen his words carefully and NOT given away too much here
    Last edited by Denial: 21/04/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.5¢ 23.5¢ 22.0¢ $65.40K 290.2K

Buyers (Bids)

No. Vol. Price($)
13 96390 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.